This clearance enables the initiation of the clinical trial addressing this significant target at the medical center within a month. The intended product, primarily for the oncology market,
Oritavancin is Targanta’s lead antibiotic candidate targeting gram-positive organisms, including methicillin-resistant Staphylococcus aureus, or MRSA. Oritavancin, administered in a single or in an infrequent dosing regimen, demonstrated comparable
Fahar Merchant, president and CEO of Protox, said: “Protox is very pleased to have completed this clinical trial ahead of schedule and looks forward to releasing top line
Chromatin immunoprecipitation (ChIP) is a technique that helps researchers understand the relationship between DNA and the proteins that impact gene regulation. The collaboration is expected to combine Millipore’s
The financing was led by Burrill & Company with participation from Novo Nordisk Biotech Fund (Novo Nordisk’s internal corporate venture fund), Yasuda Enterprise Development, GeneChem Therapeutics Venture Fund,
Dosing has been completed in the first cohort of healthy volunteer subjects in the single ascending dose, double-blind, placebo-controlled trial, which will enroll approximately 30 subjects. This study
According to the news source, drug majors are increasingly looking towards the academia to overcome limited late-stage pipelines and failures in drug development. Rise in generic competition for
Designed for the treatment of mitral valve disease, one of the most common forms of heart valve disease in the world, the Perimount Magna mitral valve is a
According to the terms of the license, Rodan + Fields Dermatologists will develop proprietary formulations for their regimen-based skincare line utilizing the new PiP3 technology with Helix’s patented
The new patent covers Rexahn’s cancer compound, RX-3117, a novel nucleoside chemotherapy agent, which is classified as an antimetabolite. This is said to be the fourth patent in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.